Literature DB >> 17412508

The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.

Yves M J J Hoybergs1, Theo F Meert.   

Abstract

The pathogenesis of diabetic neuropathy is multifactorial, but in general hyperglycemia through polyol and protein glycation pathways is considered to be a key etiological factor. Most likely insulin deficiency, in experimentally induced type I diabetes, contributes to the development of diabetes neuropathy. The aim of this study was to evaluate the in vivo behavioral effect of low-dose insulin on diabetic neuropathy in rats through behavioral testing in hyperglycemic conditions. Mechanical sensitivity and allodynia were tested in streptozotocin (STZ)-induced diabetic rats. After diabetes and neuropathy induction, treatment with low-dose insulin normalized behavioral test results in 37 days, while severe hyperglycemia persisted. Although this study provided no evidence about the role of hypoinsulinemia in the etiology of diabetes neuropathy, the results confirmed that an insulin deficit with impaired insulin signaling and neurotrophic support, rather than hyperglycemia, plays an essential role in the pathophysiology of painful diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412508     DOI: 10.1016/j.neulet.2007.02.087

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  28 in total

1.  Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.

Authors:  Xue-Hong Cao; Hee Sun Byun; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

2.  Age-dependent slowing of enteric axonal transport in insulin-resistant mice.

Authors:  Kathy J LePard; Joseph Cellini
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

3.  Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.

Authors:  Hong Yu Xue; Ya Nan Lu; Xue Mei Fang; Yong Ping Xu; Gui Zhen Gao; Li Ji Jin
Journal:  Mol Biol Rep       Date:  2012-07-19       Impact factor: 2.316

4.  Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord.

Authors:  Shao-Rui Chen; Jixiang Zhang; Hong Chen; Hui-Lin Pan
Journal:  J Pharmacol Exp Ther       Date:  2019-09-03       Impact factor: 4.030

Review 5.  Insulin resistance in the nervous system.

Authors:  Bhumsoo Kim; Eva L Feldman
Journal:  Trends Endocrinol Metab       Date:  2012-01-13       Impact factor: 12.015

Review 6.  Pharmacological treatment of diabetic neuropathic pain.

Authors:  Howard S Smith; Charles E Argoff
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

7.  Activation of the insulin-signaling pathway in sciatic nerve and hippocampus of type 1 diabetic rats.

Authors:  M R King; N J Anderson; C Liu; E Law; M Cundiff; T M Mixcoatl-Zecuatl; C G Jolivalt
Journal:  Neuroscience       Date:  2015-07-04       Impact factor: 3.590

8.  Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain.

Authors:  L J Rondón; A M Privat; L Daulhac; N Davin; A Mazur; J Fialip; A Eschalier; C Courteix
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

9.  Regression of diabetic complications by islet transplantation in the rat.

Authors:  A Remuzzi; R Cornolti; R Bianchi; M Figliuzzi; C Porretta-Serapiglia; N Oggioni; V Carozzi; L Crippa; F Avezza; F Fiordaliso; M Salio; G Lauria; R Lombardi; G Cavaletti
Journal:  Diabetologia       Date:  2009-09-30       Impact factor: 10.122

10.  Effect of sesamol on diabetes-associated cognitive decline in rats.

Authors:  Anurag Kuhad; Kanwaljit Chopra
Journal:  Exp Brain Res       Date:  2007-10-23       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.